RECENT NEWS

Capitainer has launched a fully automated sample handler that enables large-scale screening and diagnostics using the company’s self-sampling products. This technology effectively cuts down on the number of manual steps and reduces the time that laboratory staff spend preparing Capitainer samples for analysis.

MUJN Diagnostics – a subsidiary of PanGenomic Health – is partnering with Portland, Oregon-based medical diagnostic device company Hemex Health to develop a diagnostics system, which can be used to support patients being treated with alternative therapies for brain health.

The IBMS Congress continues to provide as many options to attend its highly popular programmes as it is possible to cram into a comprehensive four-day programme.

PHC and NovaScan have announced the launch of a collaboration through which they will seek to explore the feasibility of MarginScan, an investigational ex vivo medical device that will seek to support clinicians in detecting non-melanoma skin cancers (NMSC).

CrestOptics, a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, has announced the launch of CICERO, its new spinning disk confocal microscope system. Focusing on the essential elements of epifluorescence and confocal microscopy, CICERO has been developed to make high-end imaging accessible to the wider scientific community by providing a compact and cost-effective system for powerful imaging solutions.

Routine monitoring at sewage treatment works could provide a powerful early warning system for the next influenza or norovirus epidemic.

Register now for the British Society for Microbial Technology (BSMT) 38th Annual Microbiology Conference, as early bird booking rates are only available until 10 April.

Lunaphore, a Swiss life-sciences company developing technology to enable spatial biology in every laboratory, has expanded its COMET platform and product suite, which now includes a wide range of tools and applications across all research and drug development stages.

A consultation is open on recommendations that NHS England should collect and process information on healthcare activity carried out at private hospitals. Plans to create a single source of healthcare data in England to improve the quality of care for patients are the focus of a consultation which is part of the Acute Data Alignment Programme (ADAPt).

Register now for the British Society for Microbial Technology (BSMT) 38th Annual Microbiology Conference, as early bird booking rates are available until 10 April.

Source Genomics is the first UK-based commercial service provider of Olink Proteomics. The company has partnered with Olink to maximise the power of proteomics, providing high-throughput and scalable biomarker discovery for laboratory projects with unparalleled specificity.

Fujirebio has announced the availability of the Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE G immunoassay systems.

Thermo Fisher Scientific and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s Mission Bay campus.

The government has published a new plan to promote cyber resilience across the health and care sectors by 2030, protecting both services and patients.

National pharmacy retail chain Boots has announced a UK-wide diabetes screening pilot which will offer a private screening service to customers using the LumiraDx platform and HbA1c test.

Bio-Rad Laboratories has launched the new PTC Tempo 96 and PTC Tempo Deepwell thermal cyclers, designed to optimise PCR applications such as sequencing, cloning, and genotyping.

Proxim Diagnostics, a company developing a handheld, point-of care diagnostic device, announced it has received a strategic investment from bioMérieux, a world leader in the field of in vitro diagnostics.

A series of new measures will be introduced by the Medicines and Healthcare products Regulatory Agency (MHRA) with support from partners to make it faster and easier to gain approval and to run clinical trials in the UK.

PerkinElmer has successfully completed the previously announced divestiture of its applied, food and enterprise services businesses to New Mountain Capital, a growth-oriented investment firm.

Proscia, a leading provider of digital and computational pathology solutions, has strengthened its position in the $12 billion preclinical research and development (R&D) market with enhancements to its flagship Concentriq for Research platform.